India's Sun Pharmaceutical Industries Limited and Bayer have signed an agreement allowing Sun Pharma to market and distribute a second brand of the drug finerenone in India under the brand name Lyvelsa. Finerenone is a patented medicine indicated to reduce the risk of sustained decline in kidney function, end-stage kidney...
Dr. Reddy’s, Bayer, Partner to Market Heart Drug in India
Hyderabad, India-based Dr. Reddy's Laboratories Ltd. and Bayer have entered into a partnership to market and distribute a second brand of the drug Vericiguat in India. Under the agreement, Bayer has granted non-exclusive rights to Dr. Reddy's to sell Vericiguat under the brand name Gantra. Vericiguat is a soluble guanylate...
PepsiCo Wins Patent Appeal in India
In January 2023, the Delhi High Court reversed its previous decision dismissing PepsiCo's appeal against an order preventing it from enforcing a patent on a potato variety. PepsiCo had sued Indian farmers in 2019 for growing the FC5 potato variety, used to make its potato chips, claiming patent infringement. It...
India's Piramal invest in Berlin Germany R&D
Mumbai-based Piramal Enterprises is continuing research and development work in Berlin on the PET (Positron Emission Tomography) technology it acquired from Bayer Healthcare earlier this year. The initiative wil lead to early detection of Alzheimer's disease. At a press briefing, Ajay Piramal, Chairman of the Piramal Group commented on the...
Bayer AG forms a pharm joint venture to address India market
Bayer AG of Germany is forming a joint venture in Mumbai with Cadila Healthcare Ltd to distribute pharmaceuticals in Indi.. Each company will hold 50 percent of the shares in the Mumbai-based venture, which will be called Bayer Zydus Pharma. The 600 person entity will focus on women's healthcare, diagnostic...